Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (öffnet neues Fenster)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Quelle‎: Anesth Analg 2006;102(3):731-7.

Indiziert‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (öffnet neues Fenster)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (öffnet neues Fenster)

Basta MN, Stricker PA, Taylor JA.

Quelle‎: Pediatr Surg Int 2012;28(11):1059-69.

Indiziert‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (öffnet neues Fenster)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (öffnet neues Fenster)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Quelle‎: Br J Anaesth 2012;108(5):830-7.

Indiziert‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (öffnet neues Fenster)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (öffnet neues Fenster)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Quelle‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

Indiziert‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (öffnet neues Fenster)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (öffnet neues Fenster)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Quelle‎: Ann Thorac Surg 2000;70(4):1308-12.

Indiziert‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (öffnet neues Fenster)

The Bayer 022 compassionate-use pediatric study. (öffnet neues Fenster)

Coniff RF.

Quelle‎: Ann Thorac Surg 1998;65(6 Suppl):S31-3.

Indiziert‎: PubMed 9647135

https://www.ncbi.nlm.nih.gov/pubmed/9647135 (öffnet neues Fenster)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (öffnet neues Fenster)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Quelle‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indiziert‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (öffnet neues Fenster)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (öffnet neues Fenster)

Guay J, de Moerloose P, Lasne D.

Quelle‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Indiziert‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (öffnet neues Fenster)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (öffnet neues Fenster)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Quelle‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Indiziert‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (öffnet neues Fenster)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (öffnet neues Fenster)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Quelle‎: PLoS One 2015;10(5):e0126514.

Indiziert‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (öffnet neues Fenster)

Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (öffnet neues Fenster)

Lu J, Meng H, Meng Z, Sun Y, Pribis JP, Zhu C, Li Q.

Quelle‎: Int J Clin Exp Pathol 2015;8(7):7978-87.

Indiziert‎: PubMed 26339364

https://www.ncbi.nlm.nih.gov/pubmed/26339364 (öffnet neues Fenster)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (öffnet neues Fenster)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Quelle‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Indiziert‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (öffnet neues Fenster)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (öffnet neues Fenster)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Quelle‎: Br J Anaesth 2013;110(4):615-21.

Indiziert‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (öffnet neues Fenster)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (öffnet neues Fenster)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Quelle‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indiziert‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (öffnet neues Fenster)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (öffnet neues Fenster)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Quelle‎: Ann Card Anaesth 2015;18(1):23-6.

Indiziert‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (öffnet neues Fenster)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (öffnet neues Fenster)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Quelle‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indiziert‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (öffnet neues Fenster)

The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (öffnet neues Fenster)

Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA.

Quelle‎: Anesth Analg 1997;84(5):990-6.

Indiziert‎: PubMed 9141920

https://www.ncbi.nlm.nih.gov/pubmed/9141920 (öffnet neues Fenster)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (öffnet neues Fenster)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Quelle‎: Eur J Anaesthesiol 2015;32(12):844-50.

Indiziert‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (öffnet neues Fenster)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (öffnet neues Fenster)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Quelle‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

Indiziert‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (öffnet neues Fenster)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (öffnet neues Fenster)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Quelle‎: Ann Card Anaesth 2010;13(2):110-5.

Indiziert‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (öffnet neues Fenster)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (öffnet neues Fenster)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Quelle‎: Anesthesiology 2015;122(4):746-58.

Indiziert‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (öffnet neues Fenster)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (öffnet neues Fenster)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Quelle‎: Ann Thorac Surg 2011;92(3):958-63.

Indiziert‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (öffnet neues Fenster)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (öffnet neues Fenster)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Quelle‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

Indiziert‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (öffnet neues Fenster)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (öffnet neues Fenster)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Quelle‎: Ann Thorac Surg 2007;84(1):161-8.

Indiziert‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (öffnet neues Fenster)

Pediatric off-label use of recombinant factor VIIa. (öffnet neues Fenster)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Quelle‎: Pediatrics 2009;123(3):1066-72.

Indiziert‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (öffnet neues Fenster)

Factor VII for excessive bleeding following congenital heart disease surgery. (öffnet neues Fenster)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Quelle‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Indiziert‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (öffnet neues Fenster)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (öffnet neues Fenster)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Quelle‎: Paediatr Anaesth 2009;19(4):364-70.

Indiziert‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (öffnet neues Fenster)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (öffnet neues Fenster)

Guzzetta NA, Russell IA, Williams GD.

Quelle‎: Anesth Analg 2012;115(2):364-78.

Indiziert‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (öffnet neues Fenster)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (öffnet neues Fenster)

Okonta KE, Edwin F, Falase B.

Quelle‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

Indiziert‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (öffnet neues Fenster)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (öffnet neues Fenster)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Quelle‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indiziert‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (öffnet neues Fenster)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (öffnet neues Fenster)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Quelle‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indiziert‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (öffnet neues Fenster)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (öffnet neues Fenster)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Quelle‎: J Clin Anesth 2014;26(3):204-11.

Indiziert‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (öffnet neues Fenster)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (öffnet neues Fenster)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Quelle‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indiziert‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (öffnet neues Fenster)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (öffnet neues Fenster)

Tobias JD, Berkenbosch JW, Russo P.

Quelle‎: Pediatr Crit Care Med 2003;4(1):49-51.

Indiziert‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (öffnet neues Fenster)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (öffnet neues Fenster)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Quelle‎: J Intensive Care Med 2004;19(5):270-3.

Indiziert‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (öffnet neues Fenster)

Recombinant activated factor VII in cardiac surgery: a systematic review. (öffnet neues Fenster)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Quelle‎: Ann Thorac Surg 2007;83(2):707-14.

Indiziert‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (öffnet neues Fenster)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (öffnet neues Fenster)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Quelle‎: Pediatr Crit Care Med 2009;10(5):572-82.

Indiziert‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (öffnet neues Fenster)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (öffnet neues Fenster)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Quelle‎: Pediatr Cardiol 2013;34(1):119-24.

Indiziert‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (öffnet neues Fenster)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (öffnet neues Fenster)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Quelle‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indiziert‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (öffnet neues Fenster)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (öffnet neues Fenster)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Quelle‎: Artif Organs 2010;34(11):955-60.

Indiziert‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (öffnet neues Fenster)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (öffnet neues Fenster)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Quelle‎: Eur J Anaesthesiol 2014;31(6):317-26.

Indiziert‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (öffnet neues Fenster)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (öffnet neues Fenster)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Quelle‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Indiziert‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (öffnet neues Fenster)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (öffnet neues Fenster)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Quelle‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indiziert‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (öffnet neues Fenster)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (öffnet neues Fenster)

Noga T, Bruce AA, Blain H, Nahirniak S.

Quelle‎: Vox Sang 2016;110(3):253-7.

Indiziert‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (öffnet neues Fenster)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (öffnet neues Fenster)

Guay J, de Moerloose P, Lasne D.

Quelle‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Indiziert‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (öffnet neues Fenster)

Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (öffnet neues Fenster)

Macksey LF, White B.

Quelle‎: AANA J 2007;75(4):261-4.

Indiziert‎: PubMed 17711156

https://www.ncbi.nlm.nih.gov/pubmed/17711156 (öffnet neues Fenster)

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (öffnet neues Fenster)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Quelle‎: Ann Surg 2010;251(2):217-28.

Indiziert‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (öffnet neues Fenster)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (öffnet neues Fenster)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Quelle‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Indiziert‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (öffnet neues Fenster)

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (öffnet neues Fenster)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Quelle‎: Ann Card Anaesth 2012;15(1):26-31.

Indiziert‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (öffnet neues Fenster)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (öffnet neues Fenster)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Quelle‎: Artif Organs 2010;34(11):955-60.

Indiziert‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (öffnet neues Fenster)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (öffnet neues Fenster)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Quelle‎: Br J Anaesth 2015;114(1):91-102.

Indiziert‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (öffnet neues Fenster)